期刊文献+

雷帕霉素对培养的人Tenon′s囊成纤维细胞的作用 被引量:3

Role of rapamycin on cultured human Tenon′s capsule fibroblasts
下载PDF
导出
摘要 目的:观察雷帕霉素(rapamycin)对培养的人Tenon′s囊成纤维细胞的增殖及细胞周期的作用。方法:将培养的人Tenon′s囊成纤维细胞用含不同雷帕霉素浓度的培养液培养24 h后,用MTT法测定细胞的增殖情况,用流式细胞仪测定细胞周期的变化情况。结果:用含10、20、40、80和160 ng/ml雷帕霉素的培养液培养细胞时,细胞增殖抑制率分别为9.32%,22.55%,41.42%,42.25%,43.57%。细胞周期分析显示,雷帕霉素(40 ng/ml)作用后,G0/G1期细胞较对照组增多(41.76%vs 44.19%,P<0.05),S期细胞较对照组减少(45.42%vs 40.18%,P<0.05)。结论:雷帕霉素具有抑制人Tenon′s囊成纤维细胞增殖的效果,且随浓度增加抑制作用增强,并将细胞抑制在G1期的限制点内。 Objective: To explore the effect of rapamycin on the proliferation and differentiation of human Tenon's capsule fibroblasts in cell cycles. Methods: The cultured fibroblasts were treated in DMEM medium containing various concentrations of rapamyein for 24 hours. The growth of fibroblasts was measured by a methylthiazlyl tetrazolium (MTT) assay. The flow cytometry method was used to evaluate the cell cycles. Results: Proliferation of fibroblasts were suppressed by rapamycin from a dose of 10 ng/ml to 160 ng/ml( P 〈 0.05). The cell growth inhibition rate treated with mpamycin concentrations of 10 ng/ml, 20 ng/ml, 40 ng/ml, 80 ng/ml, and 160 ng/ml were 9.32%, 22.55%, 41.42%, 42.25%, and 43.57% respectively. The cell population was significantly increased at the G0/C1 phase from 41.76% to 44.19% and decreased at the S phase from 45.42% to 40.18% after the rapamycin treatment. Conclusion: Rapamycin is a potential inhibitor that blocks the proliferation of human Tenon's capsule fibroblasts at the C1 restriction point.
作者 赵杰 蔡可丽
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第6期632-634,638,共4页 Journal of Shandong University:Health Sciences
关键词 雷帕霉素 Tenon’s囊 成纤维细胞 青光眼 Rapamycin Tenon's capsule Fibroblasts Glaucoma
  • 相关文献

参考文献9

  • 1Broadway DC,Chang LP.Trabeculectomy,risk factors for failure and the preoperative state of the conjunctive[J].J Glaucoma,2001,10(3):237-249.
  • 2Laube T,Ritters B,Selbach M,et al.Clinical experiences and results of application of mitomycin C in trabeculectomy[J].Klin Monatsbl Augenheilkd,2003,220(9):618-624.
  • 3Marx SO,Jayaraman T,Go L,et al.Rapamycin FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells[J].Circ Res,1995,76(3):412-417.
  • 4Morales JM.Cardiovascular risk profile in patients treated with s irolimus after renal transplantation[J].Kidney Int Suppl,2005,93:S69-73.
  • 5Shah SA,Potter MW,Ricciardi R,et al.FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation[J].Surg Res,2001,97(2):123-130.
  • 6Bellandi F,Toso A,Maioli M,et al.Sirolimus-eluting stent for in-stent res tenosis treatment:single center results in an unselected study population[J].Ital Heart J Suppl,2005,6(9):599-603.
  • 7Reis A,Megahed M,Reinhard R,et al.Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection[J].Cornea,2002,21(1):81 -84.
  • 8Deshpande S,Zheng M,Lee S,et al.Bystander activation involving T lymphocytes in herpetic stromal keratitis[J].J Immunol,2001,167(5):2 902-2 910.
  • 9Abraham RT,Wiederrecht GJ.Immunopharmacology of rapamycin[J].Annu Rev Immunol,1996,14:483-510.

同被引文献36

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部